Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | MMP9 | P14780 | 2/20 | 0.32 |
| ▸ | MMP8 | P22894 | 2/20 | 0.32 |
| ▸ | MMP13 | P45452 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potassium Ion SCHEMBL6269201 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| Silver SCHEMBL623539 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL4580568 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL19179127 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL789396 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL10694663 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| Zinc Ion SCHEMBL4582401 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| Lithium Ion SCHEMBL21069099 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL22598032 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 | |
| SCHEMBL28573082 | 0.94 | THRB (0.42) | THRBCA1CA2MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7404943-B2 | Applying pressurized carbon dioxide gas; recrystallization by depressurization | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-07-29 | — | — | US | disclosed |
| US-20050015936-A1 | Applying pressurized carbon dioxide gas; recrystallization by depressurization | NATIONAL SCIENCE FOUNDATION | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050015936-A1 | Applying pressurized carbon dioxide gas; recrystallization by depressurization | CA3, S100P, CA2 | THRB 4556/4885CA1 13/4885CA2 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.